InvestorsHub Logo
Followers 40
Posts 1456
Boards Moderated 0
Alias Born 09/23/2013

Re: HiddenGem69 post# 14552

Monday, 09/30/2013 9:41:45 AM

Monday, September 30, 2013 9:41:45 AM

Post# of 144814
The approval of the combination for first-line use means that it is now the treatment of choice for the disease. Oddly, this news may account for the late day rally last Friday in Nuvilex, Inc.'s (OTCQB: NVLX) shares as they very well could be next in line to approach the FDA with even better data than Celgene.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News